<DOC>
	<DOCNO>NCT02661828</DOCNO>
	<brief_summary>The purpose study compare two way stop take antidepressant medication determine whether fast slow taper good tolerate .</brief_summary>
	<brief_title>Tapering Off Antidepressants</brief_title>
	<detailed_description>As abrupt cessation antidepressant medication cause distress symptom ( include limit worsened mood , irritability/agitation , anxiety , dizziness , confusion , headache ) , aim study compare tolerance two tapering regimen hypothesis taper antidepressant dose course two week yield less discontinuation symptom one week taper regimen . Additionally , suspect discontinue medication inhibit serotonin transporter ( selective serotonin reuptake inhibitors/SSRIs serotonin norepinephrine reuptake inhibitors/SNRIs ) great difference frequency discontinuation symptom two one-week taper regimen versus antidepressants n't inhibit serotonin transporter . Demographic clinical feature also identify may predict discontinuation symptom hypothesis patient SSRIs SNRIs may experience discontinuation symptom versus patient non-SSRI/SNRI medication . Whether treatment duration positively associate number discontinuation symptom also determine .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Currently take FDAapproved antidepressant least four week list approve medication : SSRIs ( citalopram , escitalopram , fluoxetine , fluvoxamine , paroxetine , sertraline , vilazodone vortioxetine ) , SNRIs ( desvenlafaxine , duloxetine , levomilnacipran , venlafaxine ) class ( amitriptyline , bupropion , desipramine , doxepin , mirtazapine , nefazodone , nortriptyline , phenelzine , selegiline , tranylcypromine ) . Clomipramine , tricyclic antidepressant approve treatment OCD , also include , class SSRI study inhibition serotonin transporter primary therapeutic mechanism . No longer wish take antidepressant medication currently prescribe , due one follow reason : 1 ) ineffective symptom ; 2 ) intolerable side effect ; 3 ) improvement illness sufficient duration clinically appropriate consider taper medication . Primary psychiatric diagnosis major depressive disorder , anxiety disorder , OCD , PTSD . Ability read understand English language . Has meet criterion time life primary psychotic disorder ( e.g . schizophrenia ) , dementia . Meets criteria DSM5defined substance use disorder within three month screen visit . Currently take two antidepressant . Presents clinically significant suicide risk , assess study physician . Presence unstable central nervous systemrelated medical illness would interfere cognition participation . Women currently pregnant lactating , plan become pregnant study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Tapering Antidepressant Regimen</keyword>
	<keyword>Antidepressant Discontinuation Syndrome</keyword>
</DOC>